| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/19/1995 | EP0560868B1 Indan derivatives |
| 04/19/1995 | EP0243446B1 Alpha tocopherol-based vesicles |
| 04/19/1995 | CN1101644A Thiadiazinones |
| 04/19/1995 | CN1028229C Heterocyclic compounds containing nitrogen and sulfur, pharmaceutical composition containing same and process for preparing them |
| 04/19/1995 | CA2117852A1 Bicyclic compounds as excitatory amino acid receptor antagonists |
| 04/18/1995 | US5407954 Arylalkoxyphenoxy-imidazoline compounds |
| 04/18/1995 | US5407951 Sulphonamidocycloalkane compounds, pharmaceutical compositions containing them, and methods of use thereof |
| 04/18/1995 | US5407935 Pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonist |
| 04/18/1995 | US5407922 Certain N-substituted-amino-alkane phosphinic acid derivatives having anti-epileptic properties |
| 04/18/1995 | US5407821 Genetic diagnosis of torsion dystonia |
| 04/18/1995 | CA1335286C Labile ketone derivatives of 3-substituted-1-alkylamino 2-propanols and their use as .beta.-adrenergic blockers |
| 04/13/1995 | WO1995009916A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 04/13/1995 | WO1995009912A1 Stem cell proliferation factor |
| 04/13/1995 | WO1995009868A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 04/13/1995 | WO1995009853A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 04/13/1995 | WO1995009838A1 INHIBITORS OF β-AMYLOID PROTEIN PRODUCTION |
| 04/13/1995 | WO1995009835A1 Novel phenylethyl and phenylpropylamines |
| 04/13/1995 | WO1995009831A1 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
| 04/13/1995 | WO1995009656A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | WO1995009654A1 Gene therapy of the nervous system |
| 04/13/1995 | WO1995009632A1 Use of penciclorin for the treatment of post-therapeutic neuralgia |
| 04/13/1995 | WO1995009619A2 Substituted urea and isothiourea derivatives as no synthase inhibitors |
| 04/13/1995 | WO1995009609A1 New emulsion formulation |
| 04/13/1995 | WO1995006727A3 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 04/13/1995 | WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 04/13/1995 | CA2173460A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 04/13/1995 | CA2173217A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | CA2172143A1 New emulsion formulation |
| 04/13/1995 | CA2171109A1 Gene therapy of the nervous system |
| 04/13/1995 | CA2150005A1 Novel phenylethyl and phenylpropylamines |
| 04/13/1995 | CA2117821A1 Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them |
| 04/12/1995 | EP0647642A1 1-Azabicyclo(3.3.0)octane derivatives and their use |
| 04/12/1995 | EP0647641A1 Substituted heterocyclylisoquinolinium salts and compositions and methods of usethereof |
| 04/12/1995 | EP0647629A1 Neurotensin active substituted 1-naphthylpyrazole-3-carboxamides, their preparation and pharmaceutical compositions containing them |
| 04/12/1995 | EP0647621A1 Aryl and heterocylic cyanoguanidine derivatives |
| 04/12/1995 | EP0647448A1 Orally administrable opioid formulations having extended duration of effect |
| 04/12/1995 | EP0647236A1 Endothelin antagonists ii |
| 04/12/1995 | EP0647231A1 N-substituted 3-azabicyclo 3.2.0]heptane derivates useful as neuroleptic agents, etc. |
| 04/12/1995 | EP0647222A1 N(hetero)-aryl-n(hetero)-tetralin-alkyl-piperazine having serotoninergic, dopaminergic and adrenergic activity |
| 04/12/1995 | EP0647137A1 Glycine receptor antagonists and the use thereof |
| 04/12/1995 | EP0647134A1 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine |
| 04/12/1995 | EP0609210B1 OPTICALLY ACTIVE 5H-PYRROLO[3,4-b]PYRAZINE DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT |
| 04/12/1995 | CN1101277A Medicine-Zhengxie San and its preparation |
| 04/12/1995 | CN1101260A Material for adjusting function of biology |
| 04/11/1995 | US5405874 Improving short term memory by administering spin-trapping agents such as N-tert-butyl-alpha-phenylnitrone, 5,5-dimethyl-1-pyrroline N-oxide or alpha-/4-pyridyl 1-oxide/-N-tert-butylnitrone |
| 04/11/1995 | US5405847 4,5-dihydro-4-oxo-pyrrolo[1,2-a]quinoxalinones and corresponding aza analogs and a process for their preparation |
| 04/11/1995 | US5405845 (Pyrrolidinyl)phenyl carbamate derivatives and use |
| 04/11/1995 | US5405840 Pranoprofen-containing, suspending medicinal composition |
| 04/11/1995 | US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin |
| 04/11/1995 | CA2002300C Compositions for the transdermal delivery of pharmaceutical actives |
| 04/08/1995 | CA2132770A1 Aryl and heterocyclic cyanoguanidine derivatives |
| 04/08/1995 | CA2132766A1 4-arylamino-benzopyran and related compounds |
| 04/06/1995 | WO1995009236A1 USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE β/A4 AMYLOID-INDUCED MORPHOLOGY |
| 04/06/1995 | CA2171553A1 Using antisense oligonucleotides to modulate nerve growth and to reverse .beta./a4 amyloid-induced morphology |
| 04/05/1995 | EP0646582A1 Useful hemi-hydrate form of a cerebral function enhancing agent |
| 04/05/1995 | EP0646374A1 Double-coated oxcarbazepine containing tablets |
| 04/05/1995 | EP0646116A1 Process and intermediates for bis-aza-bicyclic anxiolytic agents |
| 04/05/1995 | EP0646115A1 Heterocyclic-cyclic amine derivatives |
| 04/05/1995 | EP0646112A1 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 04/05/1995 | EP0646110A1 N-substitued 3-azabicyclo 3.2.0]heptane derivatives useful as neuroleptic agents etc. |
| 04/05/1995 | EP0593639B1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |
| 04/05/1995 | CN1101039A 哌嗪衍生物 Piperazine derivatives |
| 04/05/1995 | CN1100939A Lianhuangsong pill and capsule and its preparation method |
| 04/05/1995 | CN1028105C Piperidine compound and their preparation |
| 04/05/1995 | CN1028099C W-phenoxy-heterocyclic compounds |
| 04/05/1995 | CA2117669A1 Useful hemi-hydrate form of a cerebral function enhancing agent |
| 04/04/1995 | US5403951 Crystalline modification of 2-dimethylaminoethyl-n-butylaminobenzoate hydrochloride, method for production thereof and pharmaceutical preparation for anaesthesia of eyes, based thereon |
| 04/04/1995 | US5403861 Treating or preventing nerve cell death |
| 04/04/1995 | US5403851 Substituted tryptamines, phenalkylamines and related compounds |
| 04/04/1995 | US5403849 4-heterocyclophenyl-substituted dihydropyridines |
| 04/04/1995 | US5403845 Muscarinic agonists |
| 04/04/1995 | US5403837 Treating epilepsy, convulsions, schizophrenic and neurological disorders |
| 04/04/1995 | US5403731 Reacting the enzyme with a 1,1'-carbonyldimidazole-modified water-soluble polyoxyalkylene glycol |
| 03/30/1995 | WO1995008572A1 Interaction of t-cell receptors and antigen in autoimmune disease |
| 03/30/1995 | WO1995008549A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins |
| 03/30/1995 | WO1995008535A1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
| 03/30/1995 | WO1995008534A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases |
| 03/30/1995 | WO1995008462A1 Hydraulic system for anti-lock braking installations in motor vehicles |
| 03/30/1995 | WO1995008345A1 Use of growth hormone for increasement of concentration of gh, igf-i and igfbp-3 in cerebrospinal fluid |
| 03/30/1995 | WO1995008325A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease |
| 03/30/1995 | WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 03/30/1995 | CA2172605A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease |
| 03/30/1995 | CA2172529A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins |
| 03/30/1995 | CA2172512A1 Interaction of t-cell receptors and antigen in autoimmune disease |
| 03/30/1995 | CA2171448A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases |
| 03/30/1995 | CA2132896A1 Pharmaceutical compounds |
| 03/29/1995 | EP0645391A2 Aminobenzoic acid derivatives |
| 03/29/1995 | EP0645385A1 Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines |
| 03/29/1995 | EP0645370A1 Substituted m-xylylene diamines for the treatment of diseases of the central nervous system |
| 03/29/1995 | EP0645142A1 A novel physiologically active substance |
| 03/29/1995 | EP0645139A1 Use of (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidine-acetamide for the preparation of a medicament for the treatment of anxiety |
| 03/29/1995 | EP0644937A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
| 03/29/1995 | EP0644889A1 COMPOSITIONS AND METHODS FOR MODULATING $g(b)-AMYLOID |
| 03/29/1995 | EP0644885A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 03/29/1995 | EP0644882A1 Novel piperzinyl-bis(alkylamino)pyrimidine derivatives and process for preparing same |
| 03/29/1995 | EP0644878A1 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ b]AZEPINES AS NMDA RECEPTOR ANTAGONISTS |
| 03/29/1995 | EP0644877A1 Substituted-hexahydrobenzo a]phenanthridines |
| 03/29/1995 | EP0644772A1 Opioid peptides |
| 03/29/1995 | EP0644762A1 Pyrazolopyridine compounds for the treatment of anemia |
| 03/29/1995 | CN1100724A 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them |